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The major driving forces unde@nning changes in the man- 
agement of acute myocardial infarction have included greater 
understanding of the pathophysiologv of acute myocardial 
infarction, advances in patient care and monitoring, improved 
medical therapy and rapid advances in technology. These 
factors continue to play a major role, but increasingly the 
(J Am GQ C&id 1996;27~52iG32) 
impetus for change in our management stntegies lies in 
economic considerations. 
In the 194Os, based on earlier pathologic studies (1,2X 
standard practice after myocardial infarction was at least 3 to 
6 weeks of strict bed rest to allow time for infarct healing It 
became apparent that complete bed rest had serious physical 
and psychologic consequences, and progressively earlier mobi- 
lization after myocardial infarction ensued (3-S). By the early 
197Os, the duration of hospital stay after myccardial infarction 
had decreased to 2 to 3 weeks, with e&r mobilization of 
patients while in the hospital (6-8). ln the late 19705 and early 
1% numerws studies using clinical criteria to define un- 
complicated groups of post-myocardral infarction patients 
demonslratedthattheycwldbedirhargedwithknvliskas 
early as 7 to 10 days lfter infarction (9-16). 
fluring the past 10 yeam there have ken substantial 
changesinthemaaageulenlofaeutempcardial-. 
Earlierrecognitionofsignsandsymptomsofacutemyoc&iA 
iaf~cwpkdwilbnJuIioeloeofasphin(i7)aIKlIbe 
lqki develqlmellt of illterveotioaal tL?ddqy, have led to 
sign&ant impiints in outcome. However. the develop 
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ment that has had the greatest impact on survival in acute 
myocardial infarction is thromboiytic therapy (17,18). In con- 
trast, the overall management strategy for in-hospital obscrva- 
tion and rehabilitation of patients with uncomplicated infarc- 
tion has not changed substantially despite the demonstration 
as early as 1988 of the feasibility and potential economic 
impact of early (day 3) discharge of patients after reperfusion 
(19). 
We undertnok the present study to readdress the definition, 
clinical characteristics, outcomes and management of uncom- 
plicated myocardial infarction in the thrombolytic era. Based 
on previous studies, we devised simple clinical criteria for an 
uncomplicated group of post-myocardial infarction patients 
and used the Global Utilization of Streptokinase and t-PA for 
Occluded Coronary Arteries (GUSTO-I) study population to 
examine the proposal that these patients are candidates for 
discharge as early as 4 days after their acute event. 
Methods 
Patients. Our investigation included all patients enrolled in 
the GUSTO-I trial. The complete methodology of the trial has 
previously been published (20). Briefly, this large-scale trial to 
evaluate the ellicacy of various combinations of thrombolytic 
and adjunctive therapies enrolled 41,021 patients in 15 coun- 
tries at 1,081 hospitals. Patients wefe randomized to one of 
four treatment arms: streptokinase with subcutaneous heparin; 
streptokinase with intravenous heparin; accelerated tissue-type 
plasminogen activator (t-PA) with in!ravcnnus heparin; or a 
combination of streptokinase and t-PA with intravenous hep 
arin. Eligible patients ir,cluded those presenting within 6 h of 
symptom onset, haking chest pain lasting 220 min accompa- 
nied by electrocardiographic evidence for acute myocardial 
infarction (ST segment elevation >l mV in at least two limb 
leads or >2 mV in two contiguous precordial leads). Patients 
with previous stroke, recent trauma or major surgery, noncom- 
pressible vascular puncture or active bleeding, or allergy to or 
previous administration of streptokinase or anisoylated plas- 
minogen streytokinase activator complex (APSAC) l”ere 
ineligible. Severe hypertension (systolic blood pressurr 
>180 mm Hg) was a relative contraindicaticm to enrollment. 
Data coUec!ed. The primary end point of the trial was 
M-day mortality from any cause. A three-page case report 
form was used to collect and enter all demographic and clinical 
outcome information through the time of hospital discharge. 
These data included information on baseline characteristics, 
clinical presentation, major complications, procedures and 
length of stay. By interpretation of tine angiograms at the 
individual clinical sites, infarct-related artery and ejection 
fraction were determined at cardiac catheterization. Significant 
coronary artery stenosis was defined anngiographically as ~50% 
lumen narrowing of a major epicardial cxm~nary artery or its 
majorbranchesonthebasisofthe;linicalsitereading.The 
total number of arteries per patient with significant stenoses 
@MM! t0 t&C) Wa.5 tabulated t0 desnibe the extent iti 
tammaq artery dixasc. 
Definition of mpcadial irhrdon. On the basis of previ- 
ous work by our group (11,19,21,22), uncomplicatedmyocaniial 
infartiun was defined at the outset as the absence of death, 
reinfarction, ischemia, stroke, shock, heart failure (Killip class 
>I), bypass surgery, balloon pumping, emergency cardiac 
catheterization (for evaluation of signs or symptoms of clinical 
instability) or a need for cardioversion or defibrillation in the 
first 4 hapital days. Applying this definition to the GUSID- 
population delineated two groups of patients, uncomplicated 
and complicated, at hospital day 4. Adverse clinical events, also 
predelined, occurring after hospital day 4 were death within 30 
days as well as in-hospital reinfarction, recurrent iscbemia, 
shock, heart failure and stroke (see Appendix for definitions). 
Similar ana@cs were also performed defining uncomplicated 
infarction at days 3 and 5 for comparison. 
Statistics. Desirlptive statistics using medians with 25th 
and 75th percentiles for continuous variables and percentages 
for discrete variables were generated for baseline demographic 
and clinical characteristics, length of stay and clinical wents for 
both the uncomplicated and complicated groups. In light of the 
large size of the study population, which makes even single- 
unit differences sign&ant by conventional p values, we have 
omitted p values from all tables, and nonsignificant differences 
are denoted as such by NS. A given clinical event could be 
recorded only once for an individual patient, and for the 
purposes of analysis, any clinical events for which no date was 
available were considered to have occurred after the day on 
which uncomplicated was defined. Those patients were thus 
included in the uncomplicated group, and the clinical event 
was included in the calculation of the event rate for patients in 
that group. Length of stay ard clinical event rates for the 
complicated group were based on the number of patients in 
that group alive at day 4. 
Results 
Uncomplicated group patients Using cdr deli&ion of 
uncomplicated myocardial infarction to partition the 
GUSTO-I pop&&on into two groups of post-myocardial 
infarction patients, over one-half (57.3%) of all patients were 
classified as uncomplicated. Table 1 compares the baseline 
characteristics of the uncomplicated and complicated groups. 
Uncomplicated group patients were younger and more often 
male and were less likely to have hypertension and diabetes. A 
history of coronary artery disease (myocardia! infarction or 
angina) or of revascularization procedures (angioplasty or 
bypass surgery) was also less likely in the uncomplicated group. 
Uncomplicated group patients were more likely to be current 
cigarette smokers. 
COrpnrisolldcOrplicrkd8d-pWtd~pp- 
tie&. Differences in the clinical presentations of unonnpli- 
cated and complicated group patients are shown in Table 2 
There was no dikrence in time to reatment between the two 
groupsRKrewasasmalldifferencemthed&ibutiond 
ulJlgiQedandannplicatdgmup piitiennwithin the t-PA 
DlKbwMmrulawrsheparinulm~olicIInd 
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Tpbk 1. Baseline Cbfacteristics 
camplicated Unmmplicated 
(n = 17,524) (0 = 23,497) 
4369 64 (5% v 6oW.68) 
hide 12,388(70.8) 1w (77.9) 
liypertenxh’ 7J54(41.6) 8+290(35.4) 
Diabetes' 2,873(165) 3,138(13.4) 
Hype&okstet&mia* 5.790 (34.5) 7,796p.l)t 
cYurlmt~1 W(39.7) 10,613(453) 
F%miolBMl 3,414(19.6) 3J93(14.1) 
pfevhsangina 7,130(41.0) 7,919(33.9) 
ReviouscABG 882 (5.1) 902(3.9) 
ReviouxPTcA no (4.4) rm(3.7) - 
*Delined in the Append& tNonxipi8cant differem. Data presented are 
rruxiim (25th. 75th percentiles) or number (%) of patients CAEG = mrcmaty 
artery bvpars grafting; MI = trpzardial it&at&n; FKA = percutancola 
tr.lLshmidmfoMry~. 
diastolic blood pressures were higher and heart rate lower at 
presentation in the uncomplicated group, and these patients 
tended to be taller and heavier. Although inferior infarction 
was moat common in both groups, a greater proportion of 
uncomplicated (62%) than compkated (51.4%) group pa- 
tients had an inferior infarction. 
citeeteriastioe malts. In GUSTO-I, 22,701 patients un- 
derwent emerge-, elective or protocol cardiac catheteti- 
tion (Table 3). Ejection fraction was higher (55% vs. 50%) and 
coronary artery disease less extensive (605% with insignificant 
or single-vessel disease vs. 48.0%) in the uncomplicated group. 
The infarct-related artery was most often the right coronary 
artery (48%) in the uncomplicated group, but in the compli- 
cated group the infarct-related artery was nearly as often the 
left anterior descending (40.8%) as the right coronary artery 
(42.2%). The left main coronary artery was twice as often the 
Tabte 2. Clinical Characteristics at Presentation 
ciYnpkated uncomplieared p 
(n = 17,524) (n = 23.497) Value 
Tbne to treatment (h) 
Ttzabnent arm 
Streptokinase/s( hepann 
strrpt-heparin 
Accckntal t-PAW beparin 
streptokinau + I-PMV beplin 
systolic BP (mm w 
Diatdie BP @nl Hg) 
Heart rate (beaLv’ntin) 
We* lb) 
Heat @w 
MI beatlon 
Alltenor 
Ided 
ntkr 
3G.9 
24.7'7r 
25.bY< 
24.7% 
L~.o% 
126(1iQ 142) 
78(&f&9) 
76 (64.8‘4) 
~(Ufw 
17l(I65. 17s) 
3(24) NS 
2354 
25.2% NS 
25.8% 
.m% NS 
130(115.145) 
fMJ(70.90) 
7?(b28q 
79 (m. 899) 
173Ilb5.1781 
Talk 3. Results of Cardiac Catheterization 
Gmlplkated Uncompliattd 
(n = 17524) (n=23,497) due 
Card&x cathaefization 
No. of diseased ussels 
0 
1 
2 
3 
hfarct-related artery 
LAD 
Lcl 
RCA 
LMCA 
G&t 
U&UJWl 
No&e 
Ejection fraction (C) 
59.2% 
n=8.707 
6.2% 
4l.R% 
29.6% 
225% 
n=10,250 
40.8% 
10.6% 
422% 
0.6% 
2.1% 
3.6% 
0.1% 
II=&905 
50 w, w 
52.8% 
n=10,379 
11.2% 
493% 
26.0% 
135% 
ll=t2Jl?7 
327% 
126% 
48.0% 
03% 
1.4% 
4.9% 
0.2% Ns 
q =9JT23 
55(45,62)' 
*Median (25th, 75th petuntiks). IAD = kft aateriw descendhtg mmaaty 
arter.;~x=leh~mroaaryartery,~I=kftmaia~ 
arter ‘: n = number If patients with information avail&k fmm Cathetetizatm; 
RCA = ri@t mrwuv attety. 
infarct-related artery, in the compkated group as in the 
uncorupkated group. Because of substantial regional U.S. and 
interrjational differences in cardiac catheterization rates 
amorg GUSTO-I sites (21.22). these results cannot address the 
utility of catheterization as part of prediiharge risk stratifiu- 
tion. 
Adverse events. With the exception of recurrent ischemia, 
complicated group patients had more adverse clinical events 
after hospital day 4 than uncomplicated group patients (Table 
4). OK-all, cardiac event rates were very low in the uncompli- 
cated group between days 4 and 30. 
When similar analyses were performed defining umxmpli- 
cated at day 3,59.9% of patients met our criteria; at day 5, 
55.2%. There were IKI sign&ant differences in the dktriition 
of baseline demographic or clinical characteristics comparing 
day 3 or 5 with day 4 for either the uncomplicated or 
complicated group. However, there were small Merences in 
Tabk A Cardiovascular Comdications After Ho&al Dav 4 
-* UOWpbted 
(n = 15,644) (n = t3.)97) 
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T&k 5. Clinical Events; Uwmplicatcd Defined at Day 3.4 or 5 
Day 3 Day4 hYS 
(n = 24,589) (n = 23,497) (n = 2Z.W) 
bbospital mortality 0.9% 0.7% 0.61 
3oday mcutaliq 1.2% 1.0% 0.9 ii? 
Stroke 0.3% 0.2% 02% 
Reinfaretion 2.4% 1.7% 1.3% 
fbcurreat ischemia 8.9% 6.7% 4.8% 
ShOCk 05% 0.4% 0.3% 
Tabk 7. Adverse Clinical Events: Uncomplicated, bd Versus 
Alive at Day 30 
Dead at Day 30 Alit at Day 30 
(n = 237) (n = 23,147) 
Stroke 3.0% 02% 
Reinfaraion 19.2% 1.6% 
lschemia 23.7% 65% 
Shock 18.1% 02% 
Heart failure 329% 23% 
Heart failure 33% 2.6% 20% Event rates reflect events occurring after hospital day 4 in patiena unarm- 
n = number of patients identified as uncomplicated by apptying our 
definition on the days indited. Event rates are c&&ted baud on the number 
of patients detined on the given day who had events &sequent to that day. 
plicated throllgh day 4. 
rates of adverse clinical events when uncomplicated group 
patients defined at day 3.4 or 5 were compared. A summary of 
the clinical event rates for the uncomphcated group patients 
define.d on the three different darj is shown in Table 5. 
Patients who died. A comparison of the baseline charac- 
teristics of patients within the uncomplicated group who died 
by day 30 with those surviving is shown in Table 6. For those 
who died, 75% were ~66 years old, but for those surviving, 
only 25% were ‘268 yean old. The patients who died more 
often had anterior myocardial infarction (4E.j% vs. 34.1%) 
and were more likely to be female and to have other cardiac 
risk factors including hypertension, diabetes, previous myocar- 
dial infarctiq, angina and bypass surgery. They were less likely 
to be current smokers. Time to treatment was slightly longer in 
the patients who died by day 3C. Of the deaths in the. 
uncomplicated group, 68.5% occurred in hospital. The rates of 
other in-hospital complications were also higher for the subset 
of patients who died than for those who survived to day 3C 
(Table 7). When patients ~75 years old were excluded from 
TaMc 6. Baseline Characteristics: Uncomplicated. Dead Versus Table 6. Effect of Procedures on Length of Stay in 
Alive at Day 30 Uncomplicated Gmup Patients 
Dead at Day 30 
(n = 237) 
Alive at Day 30 
(n = -3,147) 
Age b) 70.9 (66.1. 7X.2) 39.8 (SM. 68.2) 
Male 6S.S% 78.fi 
Hypertension* 4S.3? 35.39 
Diibetes’ 21.3% 13.3p7 
Hypercholestemlemia’ 26-W 34.2% 
Current smoker 2.5 YT 45.5~ 
Rnious MI Ih.Jri 13.y; 
Previous angina 43.15; 33.wc; 
Previous CABG 6.W 3.n5 
Previom f7CA 1.7G 3.K 
Tiil- to treatment (h) 3.2 (2.4. 4.31 3 (2.0. 3.9) 
MI bralion 
Aotcna 483cr FI.Ipc 
McriLN 49.x 62.x 
t-hkl 3f-z 3.ui 
--- 
‘tkfmd al rrppradu Data prcuntcd arc laudma (3dl7wl penYmlr\) 
or pmT* d patiea CAKi ~mnrr?uur)hl-tM~Ml’ 
~.urdulmfurwat’lC-A pcnwamm~~rp~. 
the uncomplicated group, 30&y mortality fell from 1% to 
0.7%, but there was no change in the incidence of other clinical 
events. 
Length of stay. Information for cakulating length of r!ay 
was available for 40,096 of the 41,021 patients enrolled in 
GUSTO-I (97.7%). Studywide, the median cardiac care unit 
length of stay for complicated group patients was 4 days (25% 
longer than 6 days), and for uncomplicated group patients 3 
days; 25% of uncomplicated group patients remained in the 
cardiac care unit >5 *rays. The median overall length of stay 
for both the uncomplicated and complicated groups was 9 
days; however, when length of stay was adjusted to refIect only 
those complicated group patients alive at day 4, the median 
length of stay for that group was 10 days; 25% of patients 
uncomplicated at day 4 remained in the hospital for at least 12 
days. When only U.S. patients were considered in the Ieogtb- 
of-stay analysis, the median overall length of stay was 8 days, 
and cardiac care unit length of stay 3 days. IO the uncompli- 
cated group, diagnostic catheterization, angioplasty and by- 
Length of Stay 
kw 
L’ncumplicated MI 
ecu 30.5) 
Hospital 9(7.12) 
No dngiography 
ecu 3(L4) 
HOSpilal u;;.::; 
No PTCA 
CCU 3t2.s. 45) 
Hcnpital 9(7 12) 
NOCABG 
CCU 3(25, 45) 
Huspical 9c. 111 
No PTCA OT CAB-i 
cm J(Ls.4) 
Hcspiul U(7. II) -. 
AU rb am mdiam mitt ZSth lad 7-M PrraaJl P pwubcss 
C#utG~cllr~~~~~~ ~cudu:urcud:MI~ 
nulardul ldmctaw PrcA = pclNlMaPr t- ‘. --mIqrpbg. 
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pass surgery had only a modest relation to length of stay 
(Table 8). 
Discussion 
This large-scale trial of tltrombolytic therapy in 41,021 
patients workhvide demonstrates that simple clinical charac- 
teristics identify au uncomplicated gtoup of post-mycxardial 
infarction patients wbo can be safely discbarged from the 
hospital as early as the fourth day after infatctioo. By parti- 
tioning the GUS’IG-I population on the basis of the oceur- 
rence of predefined adverse dinical events through day 4, we 
tdentified 57.3% of all patients as uncomplicated and with very 
low risk for cardiovascular complications and death after day 4. 
These patierlts we considered candidates for early hospital 
discharge. 
I+tbMed reports. Revious studies of uncomplicated myt+ 
cardial infarction (detined by combiitions of descriptors of 
electrid stability and hemodynamic stability as well as ab 
sence of recurrent ischemia or infarction) performed before 
the widespread use of thrombolytic thew also showed that 
certain groups of patients who were at low risk for post- 
myocardial infarction complications (usually defiued as mor- 
tality or reinfarctioo) could be identified as early as 2 to 5 days 
after myocardial iufarction using simple dinical criteria similar 
to ours (23). Approximately 50% of myocardial infarction 
patients could be clarified as uxompl&ued in these studies 
They concluded that “earty” discharge (as early as day 7 to 10 
in some studies) of patients classified as uncomplicated was 
safe. The most recent of the studies involving nonlytic-treated 
patients was publii in 1993 by !Sanz et al. (24). who 
proposd discharging carefully s&c&xl groups of low risk 
patients as early as 4 days after an uncomplicated myocardial 
infarction. However, only 12.6% of their patients would have 
been eligii for early discharge. Further, their criteria re- 
quired testing to measure ejection fraction in addition to 
clinical variables. 
No studies comprising purety thrombolytic-treated uncom- 
plicated myocardii infarction patients and using solely clinical 
varhles to denti?] those suitable for early hospital discharge 
have been published to date. In a pilot study pub!isbed in 1988, 
Topol et al. (19) randomized 80 patients defined as uncompli- 
cated and low risk on the basis of clinical criteria and a 
negative treadmi!l test result 00 post-myocxdial infarction day 
3 to either very early dhxhxge (day 3) or oonventiooal 
discharge (day 7 to 10). The randomized population inch&d 
patients who received no thrombolytic therapy, thrombolytic 
tlmipy alone, artgbphty alone, or a combination of tbrom- 
bolytic tberqy sod immediate angioplasty There were no 
deaths during 6 month of fobmv-up. and arm- were 
lowittbothCutyandCXiOventional~groupsFOrtbe 
primatyemfpointoftbetri&redu&oninpatientduugeS 
tbenwasasig&anteffectofeatlydisdmrge.loadditiou 
tberewasatrendtowardeariierreturnto~iopatients 
discba@after3dayS 
patients enraIled in the Thrombolysis and Angioplaaty in 
Myocardial Infarction [TAM] 1 to 3 studies), whidt evaluated 
earlydischargeafteruncomplicatedmyocatMinfarctionin 
thrombolytic-treated patients, was by Mark et al. (25) in 1991. 
Although all patients received m therapy by proto- 
col, the regimens difiered, and a sub&&al proportion re- 
ceivedearlybalkmangioplastyaswelLIoaddition,patients 
prese-otingwitbQockor>75yearsoldwereuotiududedBy 
adefKtionofunnrtllplieatedaimilartotbatinouratudy,5896 
oftheirpatientswereunam#catedatday3.AtIeride@fng 
majorcardiavasarlarcompbcatiom4atday30,theydevebpeda 
logistic regre&on model that ideotified dinical (early StB- 
tained ventricular n+cardia or fibriMion and early cardio- 
genie shock) and angiogmphic (ejection fraction ~40% and 
multivesselcoronaryarterydisease)variab&aspted&xaof 
riskforcardiovasatlareveotsifdischargeweretooccuronday 
4. With their modeh 30% of patients were i&nti6ed as low risk 
and potentially eligible for early discharge. In Uris group, the 
3klay omtality rate was zero, aod that for late (after day 3) 
complications 4% to 6%. 
Fi.dbgshcum.ourshldyrepreseotstbelargest 
population assessed for the potential of early d&barge iu 
uncomplicated post-myocardial i&r&on patients On the 
bi3SiiOfpreviOUSWOrkbyONgroupuocomplicatedmyocardial 
infarction was prespec&d as the absence of a set of simple 
dinicalcharacteristicsatday4.A@yingthiadefini&mpst+ 
spectively to the patients in the GUSTO-1 data base parti- 
tioned them into uncomplicated and complicated groups for 
anal@s. All patients received tl~~mbolytic therapy on one of 
the four GU!STG arms, and, by our defhrition, none had 
adjunctive interventional therapy before day 4. IO addition, tbe 
inclusion criteria for the GU!S‘IG trial were r&r&d to tire 
general definition of acute myocxdial infarction, giving us a 
broad representative sample of the general populatioo pre- 
seating with acute myotxdial infarction and receiving tbrom- 
bolytic therapy. Although dataderiwd 5adjumeot” of tbe 
proposed criteria could imptuve their predictive ability mod- 
estJy,tbeadvantageofthesecriteriaistbattbeyaresimple, 
readilyrec+&dclinicaleveots,easilyassewedir~allpatieots 
presenting with acute myocanM i&u&m. There is no re- 
quirement for expensive or timeumsummg iovasiw or nonin- 
vasivetatingtodetinethelowrisLpoplktion.Wheowleapply 
our criteria, -57% of all thrombolytic-treated patients are 
uncomplicated aod would therefore be eligib!e for early bos- 
pital discharge at day 4. lbe 3Oday mortality in this dinically 
&lined group was I%. -fbe inLidence of cardiov3scular events 
otbertbandeathafterday4waslorvar&witbtheexce@ouof 
recurrent &hernia. all less than that for tbe am@icated 
group. 
Thehigberincidenceofrecurrentiscbemiaintbeumzom- 
plicatedgroupmayhavebothmetM@icanddinicalbases 
Fkcauseaspeci”rdinicalcventanddbereunckdarlyooce 
foragivenpatrent,alldinicaleveutsbeyoudtbefourthday 
maybeunde~fortbccompligtcdgoupRecmTalt 
is&miaoccurredin376%oftbean@iatedgnnlpbefore 
day4,kaviugtbrxepatieutsiueligiblefortbateventafter&y 
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4. Alternatively, complicated patients may have greater initial 
myocardial damage in the infarct-related artery territory or 
have had procedural intervention before day 4 and therefore a 
lower risk for recurrent &hernia. 
Sixty percent of patients would have been eligib!e for early 
discharge if our criteria were applied at day 3, but with slightly 
higher rates of 30day mortality, recurrent ischemis, reinfarc- 
tion and heart failure. If the criteria were applied at day 555% 
of patients would have been eligible for early discharge. 
However, there was no advantage from the standpoint of 
30day mortality of applying the criteria at day 5, and the rates 
of recurrent ischemia, reinfarction and heart failure were only 
slightly lower than at day 4. Therefore, early discharge at day 
4 seemed an acceptable compromise. 
Cost Implications. One clear implication of early discharge 
after uncomplicated myocardial infarction is the potential for 
significant reductions in hospital costs. To assess the economic 
impact of an early discharge policy, we evaluated its potential 
effect on length of stay for the GUSTO-I population. In 
GUSTO-I, the median duration of hospital stay for uncompli- 
cated myocardial infarction was 9 days, at the upper end of the 
7- to IO-day range for conventional post-myocardial infarction 
discharge. Further, 25% of uncomplicated patients remained 
in the hospital for at least 12 days, and 25% of their cardiac 
care unit stays were for 5 days or more. The reason for the 
prolonged hospital and cardiac care unit stays in uncompli- 
cated patients is unclear: 52.8% had cardiac catheterization, 
22% angioplasty and 4.4% bypass surgery before discharge. 
Even after elimination of those patients who had bypass 
surgery or angioplasty, which migh! necessitate a longer stay, 
the median length of stay was only 1 day shorter (8 days 
compared with 9 days). The median cardiac care unit length of 
stay was not related to bypass surgery or angioplasty during the 
hospital period. Similarly, there was no observed relationship 
between overall or cardiac care unit length of stay and 
pcrforntance of angiography during the hospital period when it 
did not lead to a revascularization procedure. Thus, it appears 
that delays in discharge for procedures were not a major factor 
in determining length of stay. Our data suggest very low 
cardiac event rates after day 4; thus. it is doubtful that 
complications accounted for the prolonged stays. Part of the 
prolonged length of stay may bc explained by regional differ- 
ences in practice, however; overall length of stay for the 
597 U.S. GUSTO-I sites was 8 days (vs. 9 days for the total 
GUSTO population), and 25% of U.S. patients remained in 
the hospital for >lO days. 
Regardless of factors promoting longer stays, the prolonged 
and even the conventional lengths of hospital and cardiac care 
unit Stdy in uncomplicated group patients overall and in the 
1l.S. subset could safely be shortened. If all uncomplicated 
patients m GUSTO-1 had been discharged at day 4. the median 
~xhdon in kngth of stay would have been 5 days with 
sub6tantial savings in hospital mom charges alone. When 
Topol et al. (19) investigated very e+ (day 3) versus conven- 
lional(day7tolO)~inl9811.adecreascink~of 
slay from 8-I 10 3.3 day was achkcd with a cumulative 
reduction in hospital, professional, and laboratory charges of 
39% ($5,322). 
Pdiscbarge testing. Before the use of thrombolytic ther- 
apy, and before the concept of early hospital discharge, 
exercise treadmill testing was shown to be d helpful long-term 
prognosticator when performed before discharge at 3 weeks 
after infarction (26-28). Length of stay after uncomplicated 
myocardial infarction has decrease d significantly, and exercise 
testing before discharge continues to be advocated for risk 
stratification. However, there is no evidence that it alters early 
(discharge to day 30) outcome. Studies have also suggested 
that cardiac catheterization before discharge may help to 
identify patients with high-risk anatomy or pump dysfwAon 
that may have prognostic implications (29-31). However, our 
data show that post-myocardial infarction patients in the 
uncomplicated group through day 4 in general have low risk 
coronary anatomy and good ejection fraction and are at very 
low risk for cardiovascular complications including death be- 
tween discharge and day 30. It is not clear that performing 
routine cardiac catheterization or a predischarge functional 
study (exercise treadmill test or stress nuclear or echocardio- 
graphic studies) would improve substantially on the 30day 1% 
mortal’!y in this group. However, the 3.6% l-year mortality 
does suggest that further long-range risk stratitication would bc 
helpful. Alternatives include symptom-limited stress testing on 
the day of planned discharge (shown to be safe in recent 
studies at day 6 to 7 after myocardial infarction) (32-34). 
conventional submaximal stress testing at discharge with 
symptom-limited testing at 4 to 6 weeks or early discharge with 
deferral of symptom-limited stress testing until 4 to 6 weeks. 
Further investigation would be useful to define the relative 
safety, effectiveness in risk stratifiution and cost implications 
of these strategies. 
Study llmitatioas. There are several limitations to the 
application of the results of our study. 
1. For the GUSTO-I trial, data collection stopped at the 
time of hospital discharge for all outccrmes except mortality. 
We therefore cannot directly compare rates of clinical events 
in the uncomplicated patients remaining in the hospital with 
those of the patients discharged early. For those patients 
remaining in hospital after day 4, the clinical event rates were 
very low despite close and careful monitoring. It seems likely 
that many of the complications reported in tbcse patients 
might not bc clinically apparent or clinically significant in 
discharged patients, who are not as closely obserwd It is also 
unlikely that all of the reported complications in patients 
remaining in the bital would have necessitated hoqrital 
readmission had they occurred after discharge. We therefore 
propose that thm uncomplicated group patients actually 
discharge*1 from the hospital are similar to the uncomplicated 
group patients remaining in the hospital and likewise have lowr 
rates of card iovascular complications. When we performed an 
analysis defining uncomplicated at day S instead of day 4. there 
was no significant diLrence in 30&y momdity (0.9% M 
I.W ). Further. there were onIy small dccrea~~~ in the inci- 
dcna of other clinical events after day 5 versus day 4. These 
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observations further support the safety of early discharge at 
day 4. 
2. A second potential drawback to the broad application of 
our clinical criteria is that only patients treated with thrombo- 
lytic therapy were evaluated in this study, and the study 
population was restricted to those with ST elevation. Of the 
50% of myocardial infarction patients who reach the hospital 
alive, only approximately 40% are eligible to receive thrombo- 
lytic therapy (35). It is unclear if mpr criteria would have the 
same dichotomizing effect if applied to nonlytic-treated un- 
complicated patients. However, studies in the prethrombolytic 
era showed that knilar clinical criteria effectively identified 
low-risk uncomplicated patients by day 3 to 5 post-myocardial 
infarction, for whom safe discharge at day 7 was proposed (23). 
On the basis of these studies, our criteria would be expected to 
apply to simiMy identi6ed nonlytic-treated patients as well. 
This is an area that requires further investigation. 
3. Finally, although this study shows the safety of early 
discharge and suggests the opportunity for significant reduc- 
tions in health care dollars spent for hospital room, procedures 
and professional fees, it does not address the psychosocial 
impact that an early discharge policy might have on patients 
and their families. Clearly, the home setting would have to be 
appropriate for continued cardiac rehabilitation. Even though 
uncomplicated by day 4 and candidates for early discharge, the 
elderly, those living alone, and those without access to ade- 
quate medical follow-up might benefit from more prolonged 
in-hospital observation and rehabilitation or discharge to a 
facility more appropriate to these tasks. 
‘I’& psycb&giczl @act of early discharge on the patient 
and family must also be considered. The Topol et al. (19) study 
of early discharge after myocardial infarction included predis- 
charge and postdischarge measures of psychosocial functioning 
and showed no difference between ear?y and conventional 
discharge groups on post-myocardial infaxtiua day 3 or at 1 
month after infarction. In adaitiun. there was a trend toward 
earlier return to work in the early discharge group that may 
have a beneficiai social and economic impact if borne out in 
larger groups. 
. Coaetssroas * Our study suggests that early hospital dis- 
charge of uncomplicated post-myocardial infarction patients 
identified by simple clinical characteristics available in routine 
clinical follow-up is safe as early as 4 days after the event. 
These results should be helpful in the development of rational 
practice guideiines for management of acute myocardial in- 
farction. Review of the baseline characteristics of the GUSID- 
I population suggests that younger patients (age <75 years 
old), those with inferior my&al infarction, and those 
without congestive heart failure would be good initial targets 
for early dixharge planning while continuing to monitor for 
Can#l!atiomthmughday4.Ahbough~ymortalityinthis 
dinically defined group b low, the incEase in mortality to 3.6% 
at I year suggests that further elforts to identify those patients 
at high risk after day -30 is necessary. In a&l&a. further 
inmtigation inlo both positive and negati~ m and 
socialekxsofeartydischgepolicieswiubenecded 
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Appendix 
DejMions of Adverse Clinkal Events 
Conpiwhemtfaih~~sigmasymptomsofcoqbestion 
alcwcardi4cootptbeliewltobe6e5n&ytocardiacdys%o&m 
LJiabcxHktoIyddisbetesmeniIusheforeaurent~. 
~:Hktorydacurrcotlydocumcatcdscnweboksterol 
>240q/dlorpiordiagomkbyaphy&ianvdienthep&ntmnnotnzm&xr 
anexaclvahieandwvaluekremnkdiathechmt. 
Hypauncio:HktOlyOfhypcltWSiOUbeforcCWlWtadmissioa 
J&wmu~icckmip:eteur~~~anewbypo- 
te8sion,phmnaiyedemaammmorthwghtbytheph+iaotorqfesent 
mpcardiaikchemia 
&@dion:Aseewlmpxdiai~,farctionbwdonatkarthuodthe 
fN 
1. flecuITealkchemicsyraptomsiasling>!5lnin. 
2 New=-TwawchaogesanewQwava. 
3. !&cmdekvatiooiocanJiacenqmekxktowertheoormalupperlimh 
abyafiuthermifahdyowzrtkeuppellimit 
4. Angioppbic reocdti of a docomented p&owly patent infarct- 
related artery. 
Shoclr:Systoliebloodprrssurc~90mmHgfa~lbnotRspomivetoftuid 
rPsuscitationalolK,believedtobe~loQrdiwcdpfunctan.wd 
awciatedwithsignsof~aeardisbxka~22titerslmhpcrm? 
SooLr:Acoteoewnewologicde6citrsultiqindeathalasting>24h 
clauiliedbyapb@ciaoasasn&e. 
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